The founders of Plico Biotech have expertise in biochemistry, molecular and cellular biology, nueroscience and medicine. This diverse and broad background has allowed them to define a new strategy to drug discovery.
Recent failures in clinical trials by pharmaceutical companies have highlighted the need to rethink the pharmacological strategies against neurodegenerative disorders. At Plico Biotech we decided to go back to the basis to design new drugs.
Plico derives from the Latin plicare, which means “to fold”. The proteins that we study all have the ability to fold on themselves, forming a stack of molecules. Plico Biotech is named after this feature.
Plico Biotech was incorporated in the US and it conducts research in the US and in its laboratories in Milan, Italy.